TABLE 4.

Summary Quality Score at Baseline and 12 Months by Characteristic (n = 68)

	Baseline Summary Score	P Value for Variable	12-Month Summary Score	P Value for Variable
Opioid treatment
Non-Buprenophine	48.6	0.609	47.8	0.128
Buprenorphine	45.6		51.6
Age in years
20–39	47.2	0.189	45.9	0.133
40–49	46.1		53.1
≥ 50	46.3		50.2
Gender
Male	46.3	0.193	49.8	0.066
Female	46.7		50.6
Race/ethnicity
White	44.3	0.956	48.7	0.311
Black	46.4		50.4
Latino	48.6		53.8
Other	49.4		51.2
Education
Less than high school	44.1	0.261	50.1	0.488
High school	48.2		50.0
College	48.5		54.5
Homeless
No	46.5	0.379	51.7	0.375
Yes	45.7		47.8
HIV symptom index
Lowest tertile	47.2	0.428	49.3	0.518
Middle tertile	44.4		46.8
Highest tertile	47.6		55.8
Depression score
Lowest tertile	48.9	0.379	50.2	0.754
Middle tertile	45.3		49.8
Highest tertile	44.9		52.0
ASI–drug score
Lowest tertile	47.1	0.513	50.7	0.989
Middle tertile	44.0		51.3
Highest tertile	48.2		50.1
ASI–alcohol score
Lowest tertile	45.6	0.701	50.9	0.262
Middle tertile	47.8		49.1
Highest tertile	46.6		51.2
Opioid of choice
Opioid analgesics	49.2	0.060	53.9	0.024
Heroin	44.3		48.1
Stimulant use
No	46.4	0.860	50.7	0.983
Yes	46.8		50.7
Injection drug use
No	46.7	0.877	51.6	0.551
Yes	46.3		50.0

ASI, Addiction Severity Index.